Salud financiera de hoja de balance de Expleo Solutions

Salud financiera controles de criterios 6/6

Expleo Solutions tiene un patrimonio de accionistas total de ₹5.6B y una deuda total de ₹245.7M, lo que sitúa su ratio deuda-patrimonio en 4.4%. Sus activos y pasivos totales son ₹7.3B y ₹1.7B respectivamente. El BAIT de Expleo Solutions es de ₹1.2B, por lo que su ratio de cobertura de intereses es de -70.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.3B.

Información clave

Ratio deuda-patrimonio

₹0

Deuda

Ratio de cobertura de intereses	44x
Efectivo	₹1.99b
Patrimonio	₹6.11b
Total pasivo	₹1.54b
Activos totales	₹7.65b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?

Jun 21

Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital

Mar 15

The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence

Sep 15

Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now

Aug 19

Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Jul 14

Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital

May 05

A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Mar 15

Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?

Feb 15

Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital

Jan 24

Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year

Jan 04

A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Dec 14

Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?

Nov 26

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹5.6B) de EXPLEOSOL superan a sus pasivos a corto plazo (₹1.4B).

Pasivo a largo plazo: Los activos a corto plazo de EXPLEOSOL (₹5.6B) superan a sus pasivos a largo plazo (₹312.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: EXPLEOSOL está libre de deudas.

Reducción de la deuda: EXPLEOSOL no tenía deudas hace 5 años.

Cobertura de la deuda: EXPLEOSOL no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: EXPLEOSOL no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Salud financiera de hoja de balance de Expleo Solutions

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Expleo Solutions Limited Announces Closing of Expleo Solutions FZE, UAE, Wholly Owned Subsidiary

Expleo Solutions Limited to Report Fiscal Year 2024 Results on May 23, 2024

Expleo Solutions Limited Announces Directorate Changes

New minor risk - Profit margin trend

Third quarter 2024 earnings released: EPS: ₹21.93 (vs ₹28.22 in 3Q 2023)

Expleo Solutions Limited to Report Q3, 2024 Results on Feb 07, 2024

Expleo Solutions Limited Announces Chief Financial Officer Changes

Expleo Solutions Limited Announces the Resignation of Prashant Eknath Bramhankar as Whole-Time Director & COO

Second quarter 2024 earnings released: EPS: ₹13.22 (vs ₹17.17 in 2Q 2023)

Expleo Solutions Limited to Report Q2, 2024 Results on Nov 09, 2023

Insufficient new directors

Investor sentiment deteriorates as stock falls 20%

Expleo Solutions Limited Declare Final Dividend for the Financial Year 2022-23

Expleo Solutions Limited to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: EPS: ₹86.27 (vs ₹43.61 in FY 2022)

Expleo Solutions Limited Proposes to Declare Final Dividend for Financial Year 2022-23

Upcoming dividend of ₹5.00 per share at 0.3% yield

Full year 2023 earnings released: EPS: ₹86.27 (vs ₹52.58 in FY 2022)

Expleo Solutions Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or Before September 09, 2023

Expleo Solutions Limited, Annual General Meeting, Aug 10, 2023

Third quarter 2023 earnings released: EPS: ₹28.22 (vs ₹11.10 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₹17.17 (vs ₹10.80 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹17.17 (vs ₹10.80 in 2Q 2022)

Senior Director of BFSI recently sold ₹1.3m worth of stock

Full year 2022 earnings released

Investor sentiment improved over the past week

Expleo Solutions Limited to Report Q4, 2023 Results on May 29, 2023

When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?

Senior Director of BFSI recently sold ₹5.7m worth of stock

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Expleo Solutions Limited, Annual General Meeting, Aug 11, 2022

Expleo Solutions Limited (NSEI:EXPLEOSOL) acquired Lucid Technologies & Solutions.

Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital

Senior Director of BFSI recently sold ₹1.4m worth of stock

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Insider recently sold ₹1.4m worth of stock

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹10.80 (vs ₹12.27 in 2Q 2021)

The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence

Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now

Full year 2021 earnings released: EPS ₹49.20 (vs ₹38.51 in FY 2020)

Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹49.20 (vs ₹38.51 in FY 2020)

Investor sentiment improved over the past week

Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital

Investor sentiment improved over the past week

Additional Non-Executive Director has left the company

A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?

Third quarter 2021 earnings released: EPS ₹12.30 (vs ₹9.96 in 3Q 2020)

Expleo Solutions Limited to Report Q3, 2021 Results on Feb 04, 2021

Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital

Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year

New 90-day low: ₹458

A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)

Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?

Market pulls back on stock over the past week

Second quarter 2021 earnings released: EPS ₹12.27

Expleo Solutions Limited to Report Q2, 2021 Results on Nov 25, 2020

Market bids up stock over the past week

New 90-day high: ₹571

Expleo Solutions Limited Appoints Mr. Rajesh Krishnamurthy as Additional Director (Non-Executive), Effective September 1, 2020

New 90-day high - ₹522

New 90-day high - ₹420

First quarter earnings released

Expleo Solutions Limited to Report Q1, 2021 Results on Aug 20, 2020

New 90-day high - ₹298

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera